Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Sales | 291 | 57 | 0 | 0 | 0 |
| Gross Profit | 291 | 57 | N/A | N/A | N/A |
| Operating Expenses | 31,022 | 6,957 | 5,175 | 9,622 | 6,003 |
| Operating Income | -30,731 | -6,900 | -5,175 | -9,622 | -6,003 |
| Interest Expense | 911 | 3,514 | 7,436 | 2,100 | 1,385 |
| Other Income | 211 | -11,503 | -813 | 100 | 226 |
| Pre-tax Income | -31,431 | -21,917 | -13,424 | -11,622 | -7,162 |
| Income Tax | N/A | -61 | -173 | -4,067 | N/A |
| Net Income Continuous | -31,431 | -21,856 | -13,251 | -7,555 | -7,162 |
| Net Income Discontinuous | N/A | 112 | 377 | 5,855 | -3,076 |
| Net Income | $-31,431 | $-21,744 | $-12,874 | $-1,700 | $-10,238 |
| EPS Basic Total Ops | -5,200.00 | -12,900.00 | -4,562.50 | -662.50 | -4,225.00 |
| EPS Basic Continuous Ops | -4,702.99 | -12,937.50 | -4,700.00 | -2,925.00 | -2,950.00 |
| EPS Basic Discontinuous Ops | N/A | 37.50 | 137.50 | 2,262.50 | -1,275.00 |
| EPS Diluted Total Ops | -5,200.00 | -12,900.00 | -4,562.50 | -662.50 | -4,225.00 |
| EPS Diluted Continuous Ops | -4,702.99 | -12,937.50 | -4,700.00 | -2,925.00 | -2,950.00 |
| EPS Diluted Discontinuous Ops | N/A | 37.50 | 137.50 | 2,262.50 | -1,275.00 |
| EBITDA(a) | $-30,151 | $-4,305 | $1,883 | $-8,048 | $-4,927 |